Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, March 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 124 articles:
HTML format


 

Single Articles

  1. PAHAL P, Sharma S, Montani D, Henry J, et al
    Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.
    Respiration. 2018 Feb 28. pii: 000485631. doi: 10.1159/000485631.
    Abstract    

    Abstract available

  2. YU B, Ferrari M, Schleifer G, Wepler M, et al
    Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension.
    Nitric Oxide. 2018 Feb 24. pii: S1089-8603(17)30336.
    Abstract    

    Abstract available

  3. KIM D, Lee KM, Freiman MR, Powell WR, et al
    Phosphodiesterase-5-inhibitor Therapy for Pulmonary Hypertension in the US: Actual vs Recommended Use.
    Ann Am Thorac Soc. 2018 Feb 27. doi: 10.1513/AnnalsATS.201710.
    Abstract    

    Abstract available

  4. DE MUYNCK B, Leys M, Cuypers J, Vanderschueren D, et al
    Hypocalcemia after Denosumab in a Pulmonary Hypertension Patient Receiving Epoprostenol.
    Respiration. 2018;95:139-142.
    Abstract    

    Abstract available

  5. KAWASHIMA T, Yoshitake A, Kawakami T, Shimizu H, et al
    Two-stage treatment using balloon pulmonary angioplasty and pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension.
    Ann Vasc Surg. 2018 Feb 23. pii: S0890-5096(18)30159.
    Abstract    

    Abstract available

  6. YUM SK, Kim MS, Kwun Y, Moon CJ, et al
    EXPRESS: Impact of histologic chorioamnionitis on pulmonary hypertension and respiratory outcomes in preterm infants.
    Pulm Circ. 2018 Jan 1:2045894018760166. doi: 10.1177/2045894018760166.
    Abstract    



  7. KUEBLER WM, Bonnet S, Tabuchi A
    EXPRESS: Inflammation and autoimmunity in pulmonary hypertension - is there a role for endothelial adhesion molecules?
    Pulm Circ. 2018 Jan 1:2045893218757596. doi: 10.1177/2045893218757596.
    Abstract    



  8. AL-SABEQ B, De S, Davey RA
    EXPRESS: A case of ruptured sinus of Valsalva aneurysm and reversible flow-induced pulmonary hypertension.
    Pulm Circ. 2018 Jan 1:2045894018760656. doi: 10.1177/2045894018760656.
    Abstract    



  9. YANG BQ, Assad T, O'Leary J, Xu M, et al
    EXPRESS: Racial Differences in Patients Referred for Right Heart Catheterization and Risk of Pulmonary Hypertension.
    Pulm Circ. 2018 Jan 1:2045894018764273. doi: 10.1177/2045894018764273.
    Abstract    



  10. HOPPER RK, Wang Y, DeMatteo V, Santo A, et al
    Right ventricular function mirrors clinical improvement with use of prostacyclin analogues in pediatric pulmonary hypertension.
    Pulm Circ. 2018;8:2045894018759247.
    Abstract    

    Abstract available

  11. KAYMAZ C, Akbal OY, Hakgor A, Tokgoz HC, et al
    EXPRESS: Reappraisal of the Reliability of Doppler Echocardiographic Estimations for Mean Pulmonary Artery Pressure in Patients with Pulmonary Hypertension: A Study From a Tertiary Centre Comparing Four Formulae.
    Pulm Circ. 2018 Jan 1:2045894018762270. doi: 10.1177/2045894018762270.
    Abstract    



  12. GOKANAPUDY LR, Remy KE, Karuppiah S, Melgar Humala EV, et al
    Successful Surgical Repair and Perioperative Management of 6-Month-Old With Total Anomalous Pulmonary Venous Return in a Developing Country: Considerations for the Treatment of Pulmonary Hypertension.
    Cardiol Res. 2018;9:53-58.
    Abstract    

    Abstract available

  13. KARYOFYLLIS P, Papadopoulou V, Voudris V, Matsubara H, et al
    Balloon Pulmonary Angioplasty in Patients With Thromboembolic Pulmonary Hypertension.
    Curr Treat Options Cardiovasc Med. 2018;20:13.
    Abstract    

    Abstract available

  14. WANG Y, Huang X, Leng D, Li J, et al
    DNA methylation signatures of pulmonary arterial smooth muscle cells in chronic thromboembolic pulmonary hypertension.
    Physiol Genomics. 2018 Feb 23. doi: 10.1152/physiolgenomics.00069.2017.
    Abstract    

    Abstract available

  15. BARBERA JA, Roman A, Gomez-Sanchez MA, Blanco I, et al
    Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.
    Arch Bronconeumol. 2018 Feb 19. pii: S0300-2896(17)30436.
    Abstract    

    Abstract available

  16. LEPIDA D, Papathanasiou A, Galiatsou E, Nakos G, et al
    The contribution of left heart disease in COPD patients with pulmonary hypertension.
    Hellenic J Cardiol. 2018 Feb 19. pii: S1109-9666(17)30596.
    Abstract    

    Abstract available

  17. MACLEAN MMR
    The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).
    Pulm Circ. 2018;8:2045894018759125.
    Abstract    

    Abstract available

  18. LAMMI MR, Saketkoo LA, Gordon JK, Steen VD, et al
    Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort.
    Pulm Circ. 2018;8:2045893218757404.
    Abstract    

    Abstract available

  19. SINHA A, Patti R, Ambesh P, Obiagwu C, et al
    Severe Pulmonary Hypertension Due to Adult-Onset Still's Disease.
    J Investig Med High Impact Case Rep. 2018;6:2324709618757260.
    Abstract    

    Abstract available

  20. KWAPISZEWSKA G, Crnkovic S, Stenmark KR
    A Twist on Pulmonary Vascular Remodeling: Endothelial to Mesenchymal Transition?
    Am J Respir Cell Mol Biol. 2018;58:140-141.
    Abstract    



  21. OLDHAM WM
    The Long Noncoding RNA LnRPT Puts the Brakes on Pulmonary Artery Smooth Muscle Cell Proliferation.
    Am J Respir Cell Mol Biol. 2018;58:138-139.
    Abstract    



  22. WILLIAMS JL, Cavus O, Loccoh EC, Adelman S, et al
    Defining the molecular signatures of human right heart failure.
    Life Sci. 2018;196:118-126.
    Abstract    

    Abstract available

  23. LIU M, Qin C, Xia X, Li M, et al
    Semi-quantitative assessment of pulmonary arterial hypertension associated with congenital heart disease through myocardial perfusion imaging.
    Hell J Nucl Med. 2017;20:204-210.
    Abstract    

    Abstract available

  24. CHEN J, Guo J, Cui X, Dai Y, et al
    The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.
    Am J Respir Cell Mol Biol. 2018;58:181-193.
    Abstract    

    Abstract available

  25. WALLINDER A, Pellegrino V, Fraser JF, McGiffin DC, et al
    ECMO as a bridge to non-transplant cardiac surgery.
    J Card Surg. 2017;32:514-521.
    Abstract    

    Abstract available

  26. PATEL N, Kipfmueller F
    Cardiac dysfunction in congenital diaphragmatic hernia: Pathophysiology, clinical assessment, and management.
    Semin Pediatr Surg. 2017;26:154-158.
    Abstract    

    Abstract available

  27. HUANG S, Zhu X, Huang W, He Y, et al
    Quercetin Inhibits Pulmonary Arterial Endothelial Cell Transdifferentiation Possibly by Akt and Erk1/2 Pathways.
    Biomed Res Int. 2017;2017:6147294.
    Abstract    

    Abstract available

  28. FANG M, Huang Y, Zhang Y, Ning Z, et al
    Interleukin-6 -572C/G polymorphism is associated with serum interleukin-6 levels and risk of idiopathic pulmonary arterial hypertension.
    J Am Soc Hypertens. 2017 Feb 3. pii: S1933-1711(17)30036.
    Abstract    

    Abstract available

  29. MERASHLI M, Alves J, Ames PRJ
    Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
    Semin Arthritis Rheum. 2017;46:615-624.
    Abstract    

    Abstract available

  30. DUBE BP, Vermeulen F, Laveneziana P
    Exertional Dyspnoea in Chronic Respiratory Diseases: From Physiology to Clinical Application.
    Arch Bronconeumol. 2017;53:62-70.
    Abstract    

    Abstract available

  31. SALERNO FR, Parraga G, McIntyre CW
    Why Is Your Patient Still Short of Breath? Understanding the Complex Pathophysiology of Dyspnea in Chronic Kidney Disease.
    Semin Dial. 2016 Sep 28. doi: 10.1111/sdi.12548.
    Abstract    

    Abstract available

  32. KRUPA A, Majda D, Mozgawa W, Szlek J, et al
    Physicochemical Properties of Bosentan and Selected PDE-5 Inhibitors in the Design of Drugs for Rare Diseases.
    AAPS PharmSciTech. 2017;18:1318-1331.
    Abstract    

    Abstract available

  33. WATANUKI S, Kikuchi T, Toyama T, Abe R, et al
    [Mixed connective tissue disease with pulmonary hypertension developing in a chronic myeloid leukemia patient on dasatinib treatment].
    Rinsho Ketsueki. 2018;59:174-177.
    Abstract    

    Abstract available

  34. MECHELINCK M, Hein M, Bellen S, Rossaint R, et al
    Adaptation to acute pulmonary hypertension in pigs.
    Physiol Rep. 2018;6.
    Abstract    

    Abstract available

  35. CONNOLLY M, Garfield BE, Crosby A, Morrell NW, et al
    miR-322-5p targets IGF-1 and is suppressed in the heart of rats with pulmonary hypertension.
    FEBS Open Bio. 2018;8:339-348.
    Abstract    

    Abstract available

  36. ZAJONZ TS, Sander M, Padberg W, Hecker A, et al
    A case report of acute pulmonary hypertension after hyperthermic intraperitoneal chemotherapy (HIPEC) and review of the literature.
    Ann Med Surg (Lond). 2018;27:26-31.
    Abstract    

    Abstract available

  37. MATHAI SC
    Precision medicine in pulmonary hypertension: Start with the end (point).
    Int J Cardiol. 2018;257:339-340.
    Abstract    



  38. KONSTANTINIDES SV
    Detection and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Still A Lot of Homework to Do.
    Hellenic J Cardiol. 2018 Mar 2. pii: S1109-9666(18)30077.
    Abstract    



  39. KOESTENBERGER M, Avian A, Sallmon H, Gamillscheg A, et al
    The right ventricular outflow tract in pediatric pulmonary hypertension-Data from the European Pediatric Pulmonary Vascular Disease Network.
    Echocardiography. 2018 Mar 5. doi: 10.1111/echo.13852.
    Abstract    

    Abstract available

  40. LAKSHMINRUSIMHA S, Shankaran S, Laptook A, McDonald S, et al
    Pulmonary Hypertension Associated with Hypoxic-Ischemic Encephalopathy-Antecedent Characteristics and Comorbidities.
    J Pediatr. 2018 Mar 1. pii: S0022-3476(17)31750.
    Abstract    

    Abstract available

  41. WONG M, Reyes J, Lapidus-Krol E, Chiang M, et al
    Pulmonary hypertension in congenital diaphragmatic hernia patients: Prognostic markers and long-term outcomes.
    J Pediatr Surg. 2018 Feb 7. pii: S0022-3468(18)30069.
    Abstract    

    Abstract available

  42. GUPTA A, VanLoozen D, Polimenakos AC, Murdison KA, et al
    Restoring Fetal Circulation as a Means of Bridging Treatment Prior to Surgical Repair of Anomalous Origin of the Right Pulmonary Artery from the Ascending Aorta with Persistent Pulmonary Hypertension of the Newborn.
    Pediatr Cardiol. 2018 Mar 2. pii: 10.1007/s00246-018-1849.
    Abstract    

    Abstract available

  43. OLDROYD SH, Bhardwaj A, Xiong W, Zhao Y, et al
    EXPRESS: Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia.
    Pulm Circ. 2018 Jan 1:2045894018765835. doi: 10.1177/2045894018765835.
    Abstract    

    Abstract available

  44. STRIELKOV I, Weissmann N
    Role of the Aryl Hydrocarbon Receptor in Su5416/Hypoxia-induced Pulmonary Hypertension: A New Mechanism for an "Old" Model.
    Am J Respir Cell Mol Biol. 2018;58:279-281.
    Abstract    



  45. GOYAL VK, Solanki SL, Baj B
    Pulmonary hypertension and post-operative outcome in renal transplant: A retrospective analysis of 170 patients.
    Indian J Anaesth. 2018;62:131-135.
    Abstract    

    Abstract available

  46. JASSAL A, Cavus O, Bradley EA
    Pediatric and Adolescent Pulmonary Hypertension: What Is the Risk of Undergoing Invasive Hemodynamic Testing?
    J Am Heart Assoc. 2018;7.
    Abstract    



  47. O'BYRNE ML, Kennedy KF, Kanter JP, Berger JT, et al
    Risk Factors for Major Early Adverse Events Related to Cardiac Catheterization in Children and Young Adults With Pulmonary Hypertension: An Analysis of Data From the IMPACT (Improving Adult and Congenital Treatment) Registry.
    J Am Heart Assoc. 2018;7.
    Abstract    

    Abstract available

  48. MORRIS NR, Louis M, Strugnell W, Harris J, et al
    Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH).
    BMC Pulm Med. 2018;18:40.
    Abstract    

    Abstract available

  49. PAHAL P, Sharma S, Yuhong L, Tana W, et al
    Transcriptomic profiling reveals gene expression kinetics in patients with hypoxia and high altitude pulmonary edema.
    Gene. 2018;651:200-205.
    Abstract    

    Abstract available

  50. LUNDGREN J, Radegran G

    Lakartidningen. 2017;114.
    Abstract    

    Abstract available

  51. KONOFAL E, Benzouid C, Delclaux C, Lecendreux M, et al
    Mazindol: a risk factor for pulmonary arterial hypertension?
    Sleep Med. 2017;34:168-169.
    Abstract    

    Abstract available

  52. JIANG L, Wei XB, He PC, Feng D, et al
    Value of pulmonary artery pressure in predicting in-hospital and one-year mortality after valve replacement surgery in middle-aged and aged patients with rheumatic mitral disease: an observational study.
    BMJ Open. 2017;7:e014316.
    Abstract    

    Abstract available

  53. DOMINGO E, Grignola JC, Aguilar R, Messeguer ML, et al
    Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Respir Res. 2017;18:85.
    Abstract    

    Abstract available

  54. PATIL V, Ratnayake G, Fastovets G
    Clinical 'pearls' of maternal critical care Part 2: sickle-cell disease in pregnancy.
    Curr Opin Anaesthesiol. 2017;30:326-334.
    Abstract    

    Abstract available

  55. GOLDEN J, Barry WE, Jang G, Nguyen N, et al
    Pediatric Morgagni diaphragmatic hernia: a descriptive study.
    Pediatr Surg Int. 2017;33:771-775.
    Abstract    

    Abstract available

  56. ARGULA RG, Karwa A, Lauer A, Gregg D, et al
    Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2017;14:682-689.
    Abstract    

    Abstract available

  57. JALALIAN R, Moghadamnia AA, Tamaddoni A, Khafri S, et al
    Comparing the Efficacy of Tadalafil Versus Placebo on Pulmonary Artery Systolic Pressure and Right Ventricular Function in Patients with Beta-Thalassaemia Intermedia.
    Heart Lung Circ. 2017;26:677-683.
    Abstract    

    Abstract available

  58. NICHOLSON GT, Kelleman MS, De la Uz CM, Pignatelli RH, et al
    Late outcomes in children with Shone's complex: a single-centre, 20-year experience.
    Cardiol Young. 2017;27:697-705.
    Abstract    

    Abstract available

  59. ISHIDA H, Kawazu Y, Kayatani F, Inamura N, et al
    Prognostic factors of premature closure of the ductus arteriosus in utero: a systematic literature review.
    Cardiol Young. 2017;27:634-638.
    Abstract    

    Abstract available

  60. VANDERPOOL RR, Saul M, Nouraie M, Gladwin MT, et al
    Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    JAMA Cardiol. 2018 Mar 14. pii: 2674721. doi: 10.1001/jamacardio.2018.0128.
    Abstract    

    Abstract available

  61. MIWA H, Tanabe N, Jujo T, Kato F, et al
    Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center.
    Circ J. 2018 Mar 13. doi: 10.1253/circj.CJ-17-1242.
    Abstract    

    Abstract available

  62. SAHIN M, Oguz S, Ozer S, Orem C, et al
    Successful treatment of a renal arteriovenous fistula with pulmonary hypertension occurring 38 years after nephrectomy.
    Anatol J Cardiol. 2018 Mar 13. doi: 10.14744/AnatolJCardiol.2018.65693.
    Abstract    



  63. BAZMPANI MA, Arsos G, Zarogoulidis P, Doumas A, et al
    EXPRESS: A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2018 Jan 1:2045894018768289. doi: 10.1177/2045894018768289.
    Abstract    



  64. PI L, Fu C, Lu Y, Zhou J, et al
    Vascular Endothelial Cell-Specific Connective Tissue Growth Factor (CTGF) Is Necessary for Development of Chronic Hypoxia-Induced Pulmonary Hypertension.
    Front Physiol. 2018;9:138.
    Abstract    

    Abstract available

  65. ZANELLA PB, Avila CC, de Souza CG
    Anthropometric Evaluation and Functional Assessment of Patients with Pulmonary Hypertension and its Relationship with Pulmonary Circulation Parameters and Functional Performance.
    J Am Coll Nutr. 2018 Mar 13:1-6. doi: 10.1080/07315724.2017.1417925.
    Abstract    

    Abstract available

  66. HOGAN J, Salomon R, Krid S, Bonnet D, et al
    Pulmonary hypertension in an adolescent with end-stage-renal disease-a diagnostic challenge: Answers.
    Pediatr Nephrol. 2018 Mar 12. pii: 10.1007/s00467-018-3939.
    Abstract    



  67. HOGAN J, Salomon R, Krid S, Bonnet D, et al
    Pulmonary hypertension in an adolescent with end-stage-renal disease-a diagnostic challenge: Questions.
    Pediatr Nephrol. 2018 Mar 12. pii: 10.1007/s00467-018-3931.
    Abstract    



  68. HUANG D, Cheng YY, Chan PH, Hai J, et al
    Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.
    ERJ Open Res. 2018;4.
    Abstract    

    Abstract available

  69. HAN Y, Forfia PR, Vaidya A, Mazurek JA, et al
    Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
    Open Heart. 2018;5:e000736.
    Abstract    

    Abstract available

  70. YORKE J, Deaton C, Campbell M, McGowen L, et al
    Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study.
    BMJ Open Respir Res. 2018;5:e000263.
    Abstract    

    Abstract available

  71. CURRIE BJ, Johns C, Chin M, Charalampopolous T, et al
    CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds.
    Int J Cardiol. 2018 Mar 4. pii: S0167-5273(17)36908.
    Abstract    

    Abstract available

  72. ABOUELNOUR AE, Doyle M, Thompson DV, Yamrozik J, et al
    Does Late Gadolinium Enhancement still have Value? Right Ventricular Internal Mechanical Work, Ea/Emax and Late Gadolinium Enhancement as Prognostic Markers in Patients with Advanced Pulmonary Hypertension via Cardiac MRI.
    Cardiol Res Cardiovasc Med. 2017;2017.
    Abstract    

    Abstract available

  73. CIFTCI O, Akgun NA, Yilmaz KC, Karacaglar E, et al
    Posttransplant Pulmonary Hypertension Is Correlated With Acute Rejection and Death Among Cardiac Transplant Recipients: A Single Center Study.
    Exp Clin Transplant. 2018;16.
    Abstract    

    Abstract available

  74. GOH NSL
    Pulmonary hypertension in combined pulmonary fibrosis and emphysema: A tale of two cities.
    Respirology. 2018 Mar 11. doi: 10.1111/resp.13289.
    Abstract    



  75. XIA J, Yang L, Dong L, Niu M, et al
    Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.
    Front Pharmacol. 2018;9:134.
    Abstract    

    Abstract available

  76. PESAVENTO R, Prandoni P
    Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Mar 2. pii: S0049-3848(18)30264.
    Abstract    

    Abstract available

  77. LE HIRESS M, Akagah B, Bernadat G, Tu L, et al
    Design, Synthesis and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
    J Med Chem. 2018 Mar 10. doi: 10.1021/acs.jmedchem.7b01312.
    Abstract    

    Abstract available

  78. OLDROYD SH, Bhardwaj A, Pahal P, Sharma S, et al
    [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Zhonghua Er Ke Za Zhi. 2018;56:23-28.
    Abstract    

    Abstract available

  79. SAVALE L, Chaumais MC, Dorfmuller P, Humbert M, et al
    Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
    Presse Med. 2017;46.
    Abstract    



  80. ZHAO J, Wang Y, Wang Q, Li M, et al
    Response to letter "Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues".
    Int J Cardiol. 2017;249:418.
    Abstract    



  81. AYUBI E, Safiri S
    Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues.
    Int J Cardiol. 2017;249:417.
    Abstract    



  82. TSAREVA NA, Avdeev SN, Neklyudova GV
    [A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?]
    Ter Arkh. 2017;89:100-103.
    Abstract    

    Abstract available

  83. COPELAND CA, Han B, Tiwari A, Austin ED, et al
    A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal.
    Mol Biol Cell. 2017;28:3095-3111.
    Abstract    

    Abstract available

  84. HARBAUM L, Baaske KM, Simon M, Oqueka T, et al
    Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension.
    BMC Pulm Med. 2017;17:72.
    Abstract    

    Abstract available

  85. KIMURA G, Kataoka M, Inami T, Fukuda K, et al
    Sorafenib as a potential strategy for refractory pulmonary arterial hypertension.
    Pulm Pharmacol Ther. 2017;44:46-49.
    Abstract    

    Abstract available

  86. YANG JX, Pan YY, Wang XX
    Comments to the article "Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation".
    J Mol Cell Cardiol. 2017;103:139-140.
    Abstract    



  87. SUN LY, Cai ZY, Pu J, Li J, et al
    5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Inflammation. 2017;40:806-817.
    Abstract    

    Abstract available

  88. IKUTOMI M, Minami Y, Sahara M
    Response to "Comment to the article 'Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation'".
    J Mol Cell Cardiol. 2017;103:137-138.
    Abstract    



  89. RATJEN F
    Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?
    Lancet Respir Med. 2016 Jun 9. pii: S2213-2600(16)30107.
    Abstract    



  90. HOEPER MM
    Combination or monotherapy for pulmonary arterial hypertension?
    Lancet Respir Med. 2016 Feb 26. pii: S2213-2600(16)00058.
    Abstract    



  91. ISOBE S, Kataoka M, Kawakami T, Fukuda K, et al
    Adiponectin in Chronic Thromboembolic Pulmonary Hypertension.
    Circ J. 2018 Mar 21. doi: 10.1253/circj.CJ-17-1434.
    Abstract    

    Abstract available

  92. KWON MY, Hwang N, Park YJ, Perrella MA, et al
    NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation.
    Oncotarget. 2018;9:12671-12681.
    Abstract    

    Abstract available

  93. ASTORGA CR, Gonzalez-Candia A, Candia AA, Figueroa EG, et al
    Melatonin Decreases Pulmonary Vascular Remodeling and Oxygen Sensitivity in Pulmonary Hypertensive Newborn Lambs.
    Front Physiol. 2018;9:185.
    Abstract    

    Abstract available

  94. ZHANG Q, Wang L, Zeng H, Lv Y, et al
    Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study.
    BMC Nephrol. 2018;19:70.
    Abstract    

    Abstract available

  95. CHAUDHARY KR, Stewart DJ
    Taking the Right Ventricle to 'Task' in Pulmonary Hypertension: Role of TASK1/KCNK3 in RV Dysfunction.
    Cardiovasc Res. 2018 Mar 15. pii: 4938587. doi: 10.1093.
    Abstract    



  96. STEPPAN J, Diaz-Rodriguez N, Barodka VM, Nyhan D, et al
    Focused Review of Perioperative Care of Patients with Pulmonary Hypertension and Proposal of a Perioperative Pathway.
    Cureus. 2018;10:e2072.
    Abstract    

    Abstract available

  97. SANDOVAL J
    Interventional Therapies in Pulmonary Hypertension.
    Rev Esp Cardiol (Engl Ed). 2018 Mar 12. pii: S1885-5857(18)30036.
    Abstract    

    Abstract available

  98. GU ZC, Zhang YJ, Pan MM, Zhang C, et al
    The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis.
    Medicine (Baltimore). 2018;97:e0122.
    Abstract    

    Abstract available

  99. SANTAS E, de la Espriella-Juan R, Mollar A, Valero E, et al
    Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30752.
    Abstract    

    Abstract available

  100. OGOSHI T, Tsutsui M, Kido T, Sakanashi M, et al
    Protective Role of Myelocytic Nitric Oxide Synthases Against Hypoxic Pulmonary Hypertension in Mice.
    Am J Respir Crit Care Med. 2018 Feb 26. doi: 10.1164/rccm.201709-1783.
    Abstract    

    Abstract available

  101. TAMOSIUNIENE R, Manouvakhova O, Mesange P, Saito T, et al
    A Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.
    Circ Res. 2018 Mar 15. pii: CIRCRESAHA.117.312058.
    Abstract    

    Abstract available

  102. WEATHERALD J, Chaumais MC, Montani D
    Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
    Curr Opin Pulm Med. 2017;23:392-397.
    Abstract    

    Abstract available

  103. DOUWES JM, Berger RMF
    Pediatric pulmonary arterial hypertension: on the eve of growing up.
    Curr Opin Pulm Med. 2017;23:398-403.
    Abstract    

    Abstract available

  104. HUERTAS A, Tu L, Guignabert C
    New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways.
    Curr Opin Pulm Med. 2017;23:377-385.
    Abstract    

    Abstract available

  105. CAVIEZEL C, Aruldas C, Franzen D, Ulrich S, et al
    Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension.
    Eur J Cardiothorac Surg. 2018 Mar 12. pii: 4930722. doi: 10.1093.
    Abstract    

    Abstract available

  106. GLORION M, Mercier O, Mitilian D, De Lemos A, et al
    Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.
    Eur J Cardiothorac Surg. 2018 Mar 8. pii: 4924814. doi: 10.1093.
    Abstract    

    Abstract available

  107. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    Abstract    

    Abstract available

  108. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    Abstract    

    Abstract available

  109. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    Abstract    



  110. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    Abstract    

    Abstract available

  111. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  112. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  113. GAVRA P, Denault AY, Theoret Y, Perrault LP, et al
    Pharmacokinetics and Pharmacodynamics of Nebulized and Intratracheal Milrinone in a Swine Model of Hypercapnia Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2018 Jan 31. pii: S1053-0770(18)30035.
    Abstract    

    Abstract available

  114. DUARTE AG, Lin YL, Sharma G
    Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    J Heart Lung Transplant. 2017;36:220-226.
    Abstract    

    Abstract available

  115. CLAESSEN G, La Gerche A, Petit T, Gillijns H, et al
    Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers.
    J Heart Lung Transplant. 2017;36:148-156.
    Abstract    

    Abstract available

  116. CHAKINALA MM, Feldman JP, Rischard F, Mathier M, et al
    Transition from parenteral to oral treprostinil in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2017;36:193-201.
    Abstract    

    Abstract available

  117. GALIE N, Grimminger F, Grunig E, Hoeper MM, et al
    Comparison of hemodynamic parameters in treatment-naive and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.
    J Heart Lung Transplant. 2017;36:509-519.
    Abstract    

    Abstract available

  118. HASCOET S, Baruteau AE, Humbert M, Simonneau G, et al
    Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.
    J Heart Lung Transplant. 2017;36:386-398.
    Abstract    

    Abstract available

  119. VERBELEN T, Burkhoff D, Kasama K, Delcroix M, et al
    Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle.
    J Heart Lung Transplant. 2017;36:457-465.
    Abstract    

    Abstract available

  120. VACHIERY JL, Hoeper MM, Peacock AJ, Sitbon O, et al
    Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study.
    J Heart Lung Transplant. 2017;36:399-406.
    Abstract    

    Abstract available

  121. HAQUE U, Stiver C, Rivera BK, Richards B, et al
    Right ventricular performance using myocardial deformation imaging in infants with bronchopulmonary dysplasia.
    J Perinatol. 2016 Oct 6. doi: 10.1038/jp.2016.
    Abstract    

    Abstract available

  122. ELSAYED YN, Amer R, Seshia MM
    The impact of integrated evaluation of hemodynamics using targeted neonatal echocardiography with indices of tissue oxygenation: a new approach.
    J Perinatol. 2017 Jan 19. doi: 10.1038/jp.2016.
    Abstract    

    Abstract available

  123. CHAMORRO V, Morales-Cano D, Milara J, Barreira B, et al
    Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.
    PLoS One. 2018;13:e0191239.
    Abstract    

    Abstract available

  124. KHIRFAN G, Naal T, Abuhalimeh B, Newman J, et al
    Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension.
    PLoS One. 2018;13:e0191869.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;